{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T18:02:19Z","timestamp":1788976939007,"version":"build-2803163510"},"reference-count":49,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,26]],"date-time":"2024-06-26T00:00:00Z","timestamp":1719360000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmacological Sciences"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.jphs.2024.06.005","type":"journal-article","created":{"date-parts":[[2024,6,27]],"date-time":"2024-06-27T07:37:31Z","timestamp":1719473851000},"page":"9-18","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Contribution of MLKL to the development of doxorubicin-induced cardiomyopathy and its amelioration by rapamycin"],"prefix":"10.1016","volume":"156","author":[{"given":"Masaki","family":"Shimizu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wataru","family":"Ohwada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9655-3985","authenticated-orcid":false,"given":"Toshiyuki","family":"Yano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidemichi","family":"Kouzu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuya","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshifumi","family":"Ogawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arata","family":"Osanami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Toda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Nagahama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaya","family":"Tanno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuji","family":"Miura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Kuno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masato","family":"Furuhashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9814","key":"10.1016\/j.jphs.2024.06.005_bib1","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/S0140-6736(11)61625-5","article-title":"Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100,000 women in 123 randomised trials","volume":"379","author":"Early Breast Cancer Trialists' Collaborative","year":"2012","journal-title":"Lancet"},{"issue":"22","key":"10.1016\/j.jphs.2024.06.005_bib2","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1161\/CIRCULATIONAHA.114.013777","article-title":"Early detection of anthracycline cardiotoxicity and improvement with heart failure therapy","volume":"131","author":"Cardinale","year":"2015","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.jphs.2024.06.005_bib3","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1172\/JCI72931","article-title":"Cardiotoxicity of doxorubicin is mediated through mitochondrial iron accumulation","volume":"124","author":"Ichikawa","year":"2014","journal-title":"J Clin Invest"},{"issue":"12","key":"10.1016\/j.jphs.2024.06.005_bib4","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1136\/heartjnl-2017-312103","article-title":"Anthracycline cardiotoxicity: an update on mechanisms, monitoring and prevention","volume":"104","author":"Henriksen","year":"2018","journal-title":"Heart"},{"issue":"17","key":"10.1016\/j.jphs.2024.06.005_bib5","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1161\/CIRCULATIONAHA.115.017443","article-title":"Doxorubicin blocks cardiomyocyte autophagic flux by inhibiting lysosome acidification","volume":"133","author":"Li","year":"2016","journal-title":"Circulation"},{"issue":"9","key":"10.1016\/j.jphs.2024.06.005_bib6","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.132747","article-title":"Mitochondria-dependent ferroptosis plays a pivotal role in doxorubicin cardiotoxicity","volume":"5","author":"Tadokoro","year":"2020","journal-title":"JCI Insight"},{"issue":"2","key":"10.1016\/j.jphs.2024.06.005_bib7","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/nm.4017","article-title":"CaMKII is a RIP3 substrate mediating ischemia- and oxidative stress-induced myocardial necroptosis","volume":"22","author":"Zhang","year":"2016","journal-title":"Nat Med"},{"issue":"7","key":"10.1016\/j.jphs.2024.06.005_bib8","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1073\/pnas.1821022116","article-title":"Ferroptosis as a target for protection against cardiomyopathy","volume":"116","author":"Fang","year":"2019","journal-title":"Proc Natl Acad Sci USA"},{"issue":"8","key":"10.1016\/j.jphs.2024.06.005_bib9","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.1172\/JCI43008","article-title":"MTORC1 regulates cardiac function and myocyte survival through 4E-BP1 inhibition in mice","volume":"120","author":"Zhang","year":"2010","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jphs.2024.06.005_bib10","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.yjmcc.2015.12.022","article-title":"Clinical impact of myocardial mTORC1 activation in nonischemic dilated cardiomyopathy","volume":"91","author":"Yano","year":"2016","journal-title":"J Mol Cell Cardiol"},{"issue":"34","key":"10.1016\/j.jphs.2024.06.005_bib11","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1093\/eurheartj\/ehu526","article-title":"Everolimus-responsive dilated cardiomyopathy in tuberous sclerosis","volume":"36","author":"Koyama","year":"2015","journal-title":"Eur Heart J"},{"issue":"144","key":"10.1016\/j.jphs.2024.06.005_bib12","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3003802","article-title":"Rapamycin reverses elevated mTORC1 signaling in lamin A\/C-deficient mice, rescues cardiac and skeletal muscle function, and extends survival","volume":"4","author":"Ramos","year":"2012","journal-title":"Sci Transl Med"},{"issue":"10","key":"10.1016\/j.jphs.2024.06.005_bib13","doi-asserted-by":"crossref","DOI":"10.1172\/JCI154491","article-title":"ZFP36L2 suppresses mTORc1 through a P53-dependent pathway to prevent peripartum cardiomyopathy in mice","volume":"132","author":"Kouzu","year":"2022","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jphs.2024.06.005_bib14","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.yjmcc.2017.06.008","article-title":"Suppression of autophagic flux contributes to cardiomyocyte death by activation of necroptotic pathways","volume":"108","author":"Ogasawara","year":"2017","journal-title":"J Mol Cell Cardiol"},{"issue":"12","key":"10.1016\/j.jphs.2024.06.005_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2019.165552","article-title":"mTORC1 inhibition attenuates necroptosis through RIP1 inhibition-mediated TFEB activation","volume":"1865","author":"Abe","year":"2019","journal-title":"Biochim Biophys Acta, Mol Basis Dis"},{"issue":"1","key":"10.1016\/j.jphs.2024.06.005_bib16","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1038\/s41467-021-21841-w","article-title":"mTORC1 couples cyst(e)ine availability with GPX4 protein synthesis and ferroptosis regulation","volume":"12","author":"Zhang","year":"2021","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.jphs.2024.06.005_bib17","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.bbrc.2019.12.027","article-title":"Dexrazoxane ameliorates doxorubicin-induced cardiotoxicity by inhibiting both apoptosis and necroptosis in cardiomyocytes","volume":"523","author":"Yu","year":"2020","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jphs.2024.06.005_bib18","doi-asserted-by":"crossref","first-page":"666","DOI":"10.3389\/fimmu.2020.00666","article-title":"Necrostatin-1 ameliorates neutrophilic inflammation in asthma by suppressing MLKL phosphorylation to inhibiting NETs release","volume":"11","author":"Han","year":"2020","journal-title":"Front Immunol"},{"issue":"2","key":"10.1016\/j.jphs.2024.06.005_bib19","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.jphs.2022.12.009","article-title":"Nuclear translocation of MLKL enhances necroptosis by a RIP1\/RIP3-independent mechanism in H9c2 cardiomyoblasts","volume":"151","author":"Ino","year":"2023","journal-title":"J Pharmacol Sci"},{"issue":"5","key":"10.1016\/j.jphs.2024.06.005_bib20","doi-asserted-by":"crossref","first-page":"3435","DOI":"10.1002\/ehf2.14059","article-title":"Enhanced nuclear localization of phosphorylated MLKL predicts adverse events in patients with dilated cardiomyopathy","volume":"9","author":"Fujita","year":"2022","journal-title":"ESC Heart Fail"},{"issue":"6","key":"10.1016\/j.jphs.2024.06.005_bib21","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1016\/j.cell.2012.11.001","article-title":"The hairpin-type tail-anchored SNARE syntaxin 17 targets to autophagosomes for fusion with endosomes\/lysosomes","volume":"151","author":"Itakura","year":"2012","journal-title":"Cell"},{"issue":"10","key":"10.1016\/j.jphs.2024.06.005_bib22","doi-asserted-by":"crossref","first-page":"2680","DOI":"10.1080\/15548627.2020.1823124","article-title":"New insights regarding SNARE proteins in autophagosome-lysosome fusion","volume":"17","author":"Tian","year":"2021","journal-title":"Autophagy"},{"key":"10.1016\/j.jphs.2024.06.005_bib23","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.yjmcc.2017.10.003","article-title":"TFEB activation protects against cardiac proteotoxicity via increasing autophagic flux","volume":"113","author":"Pan","year":"2017","journal-title":"J Mol Cell Cardiol"},{"issue":"6","key":"10.1016\/j.jphs.2024.06.005_bib24","doi-asserted-by":"crossref","first-page":"803","DOI":"10.3390\/biom11060803","article-title":"The role of the key effector of necroptotic cell death, MLKL, in mouse models of disease","volume":"11","author":"Tovey Crutchfield","year":"2021","journal-title":"Biomolecules"},{"issue":"7","key":"10.1016\/j.jphs.2024.06.005_bib25","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1038\/cdd.2017.65","article-title":"Initiation and execution mechanisms of necroptosis: an overview","volume":"24","author":"Grootjans","year":"2017","journal-title":"Cell Death Differ"},{"issue":"1","key":"10.1016\/j.jphs.2024.06.005_bib26","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-70765-w","article-title":"C57BL\/6J substrain differences in response to high-fat diet intervention","volume":"10","author":"Siersbaek","year":"2020","journal-title":"Sci Rep"},{"issue":"6","key":"10.1016\/j.jphs.2024.06.005_bib27","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1021\/tx200143x","article-title":"Mispairing C57BL\/6 substrains of genetically engineered mice and wild-type controls can lead to confounding results as it did in studies of JNK2 in acetaminophen and concanavalin A liver injury","volume":"24","author":"Bourdi","year":"2011","journal-title":"Chem Res Toxicol"},{"issue":"3","key":"10.1016\/j.jphs.2024.06.005_bib28","doi-asserted-by":"crossref","first-page":"H397","DOI":"10.1152\/ajpheart.00088.2013","article-title":"Substrain specific response to cardiac pressure overload in C57BL\/6 mice","volume":"305","author":"Garcia-Menendez","year":"2013","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"4","key":"10.1016\/j.jphs.2024.06.005_bib29","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1007\/s00125-005-1680-z","article-title":"A genetic and physiological study of impaired glucose homeostasis control in C57BL\/6J mice","volume":"48","author":"Toye","year":"2005","journal-title":"Diabetologia"},{"issue":"4","key":"10.1016\/j.jphs.2024.06.005_bib30","doi-asserted-by":"crossref","first-page":"C666","DOI":"10.1152\/ajpcell.00607.2020","article-title":"Regulation of immune cell function by nicotinamide nucleotide transhydrogenase","volume":"322","author":"Regan","year":"2022","journal-title":"Am J Physiol Cell Physiol"},{"issue":"38","key":"10.1016\/j.jphs.2024.06.005_bib31","doi-asserted-by":"crossref","first-page":"20173","DOI":"10.1074\/jbc.M116.730473","article-title":"The contribution of nicotinamide nucleotide transhydrogenase to peroxide detoxification is dependent on the respiratory state and counterbalanced by other sources of NADPH in liver mitochondria","volume":"291","author":"Ronchi","year":"2016","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jphs.2024.06.005_bib32","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2023.1154621","article-title":"Loss of Nicotinamide nucleotide transhydrogenase sensitizes embryos to ethanol-induced neural crest and neural apoptosis via generation of reactive oxygen species","volume":"17","author":"Mazumdar","year":"2023","journal-title":"Front Neurosci"},{"key":"10.1016\/j.jphs.2024.06.005_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2020.101650","article-title":"Nicotinamide nucleotide transhydrogenase (NNT) regulates mitochondrial ROS and endothelial dysfunction in response to angiotensin II","volume":"36","author":"Rao","year":"2020","journal-title":"Redox Biol"},{"issue":"2","key":"10.1016\/j.jphs.2024.06.005_bib34","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1538\/expanim.58.141","article-title":"Genetic differences among C57BL\/6 substrains","volume":"58","author":"Mekada","year":"2009","journal-title":"Exp Anim"},{"issue":"2","key":"10.1016\/j.jphs.2024.06.005_bib35","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41418-022-01061-5","article-title":"MLKL post-translational modifications: road signs to infection, inflammation and unknown destinations","volume":"30","author":"Liccardi","year":"2023","journal-title":"Cell Death Differ"},{"issue":"4","key":"10.1016\/j.jphs.2024.06.005_bib36","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/s41419-020-2483-3","article-title":"A necroptotic-independent function of MLKL in regulating endothelial cell adhesion molecule expression","volume":"11","author":"Dai","year":"2020","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.jphs.2024.06.005_bib37","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.815916","article-title":"MicroRNA-194-5p attenuates doxorubicin-induced cardiomyocyte apoptosis and endoplasmic reticulum stress by targeting P21-activated kinase 2","volume":"9","author":"Fa","year":"2022","journal-title":"Front Cardiovasc Med"},{"issue":"1","key":"10.1016\/j.jphs.2024.06.005_bib38","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/cbdd.14104","article-title":"Upregulation of miR-144-3p alleviates Doxorubicin-induced heart failure and cardiomyocytes apoptosis via SOCS2\/PI3K\/AKT axis","volume":"101","author":"Zhang","year":"2023","journal-title":"Chem Biol Drug Des"},{"issue":"2","key":"10.1016\/j.jphs.2024.06.005_bib39","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/s41556-017-0022-y","article-title":"RIP3 targets pyruvate dehydrogenase complex to increase aerobic respiration in TNF-induced necroptosis","volume":"20","author":"Yang","year":"2018","journal-title":"Nat Cell Biol"},{"issue":"7","key":"10.1016\/j.jphs.2024.06.005_bib40","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1161\/CIRCRESAHA.119.314681","article-title":"Mitochondrial determinants of doxorubicin-induced cardiomyopathy","volume":"126","author":"Wallace","year":"2020","journal-title":"Circ Res"},{"issue":"1","key":"10.1016\/j.jphs.2024.06.005_bib41","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s12964-023-01077-5","article-title":"Role of oxidative stress and inflammation-related signaling pathways in doxorubicin-induced cardiomyopathy","volume":"21","author":"Shi","year":"2023","journal-title":"Cell Commun Signal"},{"issue":"6","key":"10.1016\/j.jphs.2024.06.005_bib42","doi-asserted-by":"crossref","first-page":"E961","DOI":"10.1073\/pnas.1613305114","article-title":"Active MLKL triggers the NLRP3 inflammasome in a cell-intrinsic manner","volume":"114","author":"Conos","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"10.1016\/j.jphs.2024.06.005_bib43","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1002\/ejhf.1138","article-title":"The innate immune system in chronic cardiomyopathy: a European Society of Cardiology (ESC) scientific statement from the Working Group on Myocardial Function of the ESC","volume":"20","author":"Frantz","year":"2018","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jphs.2024.06.005_bib44","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.1055911","article-title":"MicroRNAs in doxorubicin-induced cardiotoxicity: the DNA damage response","volume":"13","author":"Kawano","year":"2022","journal-title":"Front Pharmacol"},{"issue":"1","key":"10.1016\/j.jphs.2024.06.005_bib45","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.immuni.2017.06.001","article-title":"MLKL, the protein that mediates necroptosis, also regulates endosomal trafficking and extracellular vesicle generation","volume":"47","author":"Yoon","year":"2017","journal-title":"Immunity"},{"issue":"5","key":"10.1016\/j.jphs.2024.06.005_bib46","doi-asserted-by":"crossref","DOI":"10.1242\/jcs.220996","article-title":"Activated MLKL attenuates autophagy following its translocation to intracellular membranes","volume":"132","author":"Frank","year":"2019","journal-title":"J Cell Sci"},{"issue":"3","key":"10.1016\/j.jphs.2024.06.005_bib47","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.jhep.2020.03.023","article-title":"MLKL-dependent signaling regulates autophagic flux in a murine model of non-alcohol-associated fatty liver and steatohepatitis","volume":"73","author":"Wu","year":"2020","journal-title":"J Hepatol"},{"issue":"8","key":"10.1016\/j.jphs.2024.06.005_bib48","doi-asserted-by":"crossref","first-page":"e166","DOI":"10.1161\/CIRCRESAHA.121.319104","article-title":"atg7-Based autophagy activation reverses doxorubicin-induced cardiotoxicity","volume":"129","author":"Wang","year":"2021","journal-title":"Circ Res"},{"issue":"1","key":"10.1016\/j.jphs.2024.06.005_bib49","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1038\/s41598-018-37862-3","article-title":"Doxorubicin-induced cardiomyopathy associated with inhibition of autophagic degradation process and defects in mitochondrial respiration","volume":"9","author":"Abdullah","year":"2019","journal-title":"Sci Rep"}],"container-title":["Journal of Pharmacological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1347861324000446?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1347861324000446?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,27]],"date-time":"2024-07-27T06:25:12Z","timestamp":1722061512000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1347861324000446"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S1347861324000446"],"URL":"https:\/\/doi.org\/10.1016\/j.jphs.2024.06.005","relation":{},"ISSN":["1347-8613"],"issn-type":[{"value":"1347-8613","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Contribution of MLKL to the development of doxorubicin-induced cardiomyopathy and its amelioration by rapamycin","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmacological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jphs.2024.06.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Production and hosting by Elsevier B.V. on behalf of Japanese Pharmacological Society.","name":"copyright","label":"Copyright"}]}}